Cargando…

新型凝血标记物在肝移植术后早期并发症中的应用价值

OBJECTIVE: To investigate the relationship between thrombin-antithrombin complex (TAT), plasmin-α(2)-plasmininhibitor complex (PIC), soluble thrombomodulin (sTM), and tissue plasminogen activator-inhibitor complex (tPAIC) and postoperative complications in the early stage after liver transplantation...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 四川大学学报(医学版)编辑部 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579085/
https://www.ncbi.nlm.nih.gov/pubmed/37866963
http://dx.doi.org/10.12182/20230960105
_version_ 1785121647573860352
collection PubMed
description OBJECTIVE: To investigate the relationship between thrombin-antithrombin complex (TAT), plasmin-α(2)-plasmininhibitor complex (PIC), soluble thrombomodulin (sTM), and tissue plasminogen activator-inhibitor complex (tPAIC) and postoperative complications in the early stage after liver transplantation (LT). METHODS: We analyzed the perioperative clinical data, including plasma TAT, PIC, sTM, and tPAIC, of 130 post-LT patients admitted to the intensive care unit (ICU), West China Hospital, Sichuan University between December 2021 and November 2022. Patients were divided into two groups, a complication group and a non-complication group, according to whether they experienced complications of Clavien-Dindo (CD) grade Ⅲb and above within 30 days after the surgery. Univariate analysis and binary multivariate logistic regression models were used to determine the risk factors for complications within 30 days post-LT. RESULTS: The incidence of complications of CD grade Ⅲb and above within 30 days post-LT was 33.1% (43/130). Patients in the complication group had significantly higher scores for the Model for End-Stage Liver Disease (MELD), operative time, intraoperative red blood cell transfusion volume, intraoperative plasma transfusion volume, and plasma TAT, PIC, sTM and tPAIC measured at the time of admission to ICU after the operation than those in the non-complication group did (all P<0.05). Logistic regression showed that for every single U of red blood cells transfused during the transplant surgery, the probabilities of complications within 30 days post-LT increased by 15.1% (95% confidence interval [CI]: 1.070-1.239, P<0.001) and for the increase of every single TU/mL of plasma sTM measured upon post-LT admission to ICU, the probabilities of complications increased by 13.7% (95% CI: 1.060-1.220, P<0.001). CONCLUSION: Plasma sTM measured upon admission to ICU after LT is an independent risk factor for complications within 30 days post-LT, and additional assessment of sTM may help predict complications in the early stage post-LT.
format Online
Article
Text
id pubmed-10579085
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher 四川大学学报(医学版)编辑部
record_format MEDLINE/PubMed
spelling pubmed-105790852023-10-18 新型凝血标记物在肝移植术后早期并发症中的应用价值 Sichuan Da Xue Xue Bao Yi Xue Ban 临床研究 OBJECTIVE: To investigate the relationship between thrombin-antithrombin complex (TAT), plasmin-α(2)-plasmininhibitor complex (PIC), soluble thrombomodulin (sTM), and tissue plasminogen activator-inhibitor complex (tPAIC) and postoperative complications in the early stage after liver transplantation (LT). METHODS: We analyzed the perioperative clinical data, including plasma TAT, PIC, sTM, and tPAIC, of 130 post-LT patients admitted to the intensive care unit (ICU), West China Hospital, Sichuan University between December 2021 and November 2022. Patients were divided into two groups, a complication group and a non-complication group, according to whether they experienced complications of Clavien-Dindo (CD) grade Ⅲb and above within 30 days after the surgery. Univariate analysis and binary multivariate logistic regression models were used to determine the risk factors for complications within 30 days post-LT. RESULTS: The incidence of complications of CD grade Ⅲb and above within 30 days post-LT was 33.1% (43/130). Patients in the complication group had significantly higher scores for the Model for End-Stage Liver Disease (MELD), operative time, intraoperative red blood cell transfusion volume, intraoperative plasma transfusion volume, and plasma TAT, PIC, sTM and tPAIC measured at the time of admission to ICU after the operation than those in the non-complication group did (all P<0.05). Logistic regression showed that for every single U of red blood cells transfused during the transplant surgery, the probabilities of complications within 30 days post-LT increased by 15.1% (95% confidence interval [CI]: 1.070-1.239, P<0.001) and for the increase of every single TU/mL of plasma sTM measured upon post-LT admission to ICU, the probabilities of complications increased by 13.7% (95% CI: 1.060-1.220, P<0.001). CONCLUSION: Plasma sTM measured upon admission to ICU after LT is an independent risk factor for complications within 30 days post-LT, and additional assessment of sTM may help predict complications in the early stage post-LT. 四川大学学报(医学版)编辑部 2023-09-20 /pmc/articles/PMC10579085/ /pubmed/37866963 http://dx.doi.org/10.12182/20230960105 Text en © 2023《四川大学学报(医学版)》编辑部 版权所有 https://creativecommons.org/licenses/by-nc/4.0/开放获取 本文遵循知识共享署名—非商业性使用4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时标明是否对原文作了修改;不得将本文用于商业目的。CC BY-NC 4.0许可协议访问 https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC 4.0). In other words, the full-text content of the journal is made freely available for third-party users to copy and redistribute in any medium or format, and to remix, transform, and build upon the content of the journal. You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may not use the content of the journal for commercial purposes. For more information about the license, visit https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 临床研究
新型凝血标记物在肝移植术后早期并发症中的应用价值
title 新型凝血标记物在肝移植术后早期并发症中的应用价值
title_full 新型凝血标记物在肝移植术后早期并发症中的应用价值
title_fullStr 新型凝血标记物在肝移植术后早期并发症中的应用价值
title_full_unstemmed 新型凝血标记物在肝移植术后早期并发症中的应用价值
title_short 新型凝血标记物在肝移植术后早期并发症中的应用价值
title_sort 新型凝血标记物在肝移植术后早期并发症中的应用价值
topic 临床研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579085/
https://www.ncbi.nlm.nih.gov/pubmed/37866963
http://dx.doi.org/10.12182/20230960105
work_keys_str_mv AT xīnxíngníngxuèbiāojìwùzàigānyízhíshùhòuzǎoqībìngfāzhèngzhōngdeyīngyòngjiàzhí
AT xīnxíngníngxuèbiāojìwùzàigānyízhíshùhòuzǎoqībìngfāzhèngzhōngdeyīngyòngjiàzhí
AT xīnxíngníngxuèbiāojìwùzàigānyízhíshùhòuzǎoqībìngfāzhèngzhōngdeyīngyòngjiàzhí
AT xīnxíngníngxuèbiāojìwùzàigānyízhíshùhòuzǎoqībìngfāzhèngzhōngdeyīngyòngjiàzhí
AT xīnxíngníngxuèbiāojìwùzàigānyízhíshùhòuzǎoqībìngfāzhèngzhōngdeyīngyòngjiàzhí
AT xīnxíngníngxuèbiāojìwùzàigānyízhíshùhòuzǎoqībìngfāzhèngzhōngdeyīngyòngjiàzhí
AT xīnxíngníngxuèbiāojìwùzàigānyízhíshùhòuzǎoqībìngfāzhèngzhōngdeyīngyòngjiàzhí